Inactive Instrument
Quest PharmaTech Inc Share Price Toronto S.E.
Stocks
QPT
CA74836M1068
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 42.28L 29.81L 26.15L 24.14L 22.31L 29Cr 43.13L 2.9Cr 1.13Cr 14Cr 1.12Cr 1.09Cr 48Cr | P/E 2025 |
-3.29x | P/E 2026 | 1.18x |
|---|---|---|---|---|---|
| Enterprise Value | 52.14L 36.76L 32.24L 29.77L 27.51L 35Cr 53.18L 3.58Cr 1.39Cr 17Cr 1.38Cr 1.35Cr 60Cr | EV / Sales 2025 |
-
| EV / Sales 2026 | - |
| Free-Float |
83.12% | Yield 2025 * |
-
| Yield 2026 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 17/06/2004 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 01/01/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 17/06/2004 | |
J. Lievonen
CHM | Chairman | - | 05/07/2021 |
Jeffrey Shon
BRD | Director/Board Member | - | 05/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -15.38% | - | - | 29.8L | ||
| -0.24% | +1.85% | +3.13% | +8.40% | 4.97TCr | ||
| -0.39% | +1.16% | +420.53% | +597.10% | 4.05TCr | ||
| -2.76% | +3.71% | +23.34% | +56.62% | 3.43TCr | ||
| -2.28% | -0.15% | +23.36% | -7.54% | 3.48TCr | ||
| -0.79% | +2.02% | +3.83% | +36.42% | 2.7TCr | ||
| +3.08% | +2.43% | - | - | 1.66TCr | ||
| -3.01% | -2.57% | +64.22% | +119.04% | 1.56TCr | ||
| -2.15% | +6.87% | +104.72% | +102.56% | 1.43TCr | ||
| -2.70% | -2.04% | +12.37% | +17.77% | 1.38TCr | ||
| Average | -1.24% | +3.99% | +81.94% | +116.30% | 2.74TCr | |
| Weighted average by Cap. | -1.41% | +4.37% | +93.79% | +134.05% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | - | - |
| Net income | -18.01L -12.7L -11.14L -10.28L -10L -12Cr -18.37L -1.24Cr -48.03L -5.95Cr -47.69L -46.64L -21Cr | 49.98L 35.24L 30.91L 28.54L 26.37L 34Cr 50.98L 3.43Cr 1.33Cr 17Cr 1.32Cr 1.29Cr 57Cr |
| Net Debt | 8L 6L 5L 5L 4L 5.37Cr 8L 54.56L 21.2L 2.63Cr 21.05L 20.59L 9.12Cr | 10L 7L 6L 6L 5L 6.65Cr 10.05L 67.65L 26.29L 3.26Cr 26.1L 25.53L 11Cr |
Employees
-
















